These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3785021)

  • 1. [An international ethics commission. 9 years' experiences in the evaluation of protocols and drug trials].
    Kersting F; Seyberth HW
    Med Klin (Munich); 1986 May; 81(11):405-8. PubMed ID: 3785021
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethical issues in clinical and industry-sponsored research.
    Bhagat K; Kurashe J; Nyazema NZ
    Cent Afr J Med; 2000 Apr; 46(4):108-11. PubMed ID: 11210340
    [No Abstract]   [Full Text] [Related]  

  • 3. [National and international legislative aspects of the neuropsychopharmacologic experimentation].
    Campailla G
    Minerva Med; 1972 Nov; 63(81):4399-403. PubMed ID: 4565684
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical drug trials. Regulation, coordination and significance of "Good Clinical Practice"].
    Hvidberg EF
    Ugeskr Laeger; 1994 Feb; 156(6):789-93. PubMed ID: 8016980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Symposium on Clinical Pharmacology. Introduction.
    Smahel O
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):3-5. PubMed ID: 4924327
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trial committees in Europe.
    Avendaño C
    Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():19. PubMed ID: 9800723
    [No Abstract]   [Full Text] [Related]  

  • 7. International collaborative group on clinical trial registries. Position paper and consensus recommendations on clinical trial registries. Ad Hoc Working Party of the International Collaborative Group on Clinical Trials Registries.
    Clin Trials Metaanal; 1993 Aug; 28(4-5):255-66. PubMed ID: 10146333
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical research on humans: regulation in Switzerland, the European Union, and the United States.
    Schott M
    Food Drug Law J; 2005; 60(1):45-77. PubMed ID: 15940854
    [No Abstract]   [Full Text] [Related]  

  • 9. Good clinical research practice in Canada.
    Chen MJ; Scarth BJ; Slack CJ
    CMAJ; 1994 Nov; 151(9):1255-7. PubMed ID: 7954173
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Medico-legal Commission of Monaco. Additional protocols to the Geneva Convention of 12 August 1949 and their protective powers].
    Ann Droit Int Med; 1980-1981; (29):38-82. PubMed ID: 7282024
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical drug trials. Part 2. Legal regulations, (EG-) guidelines, ethics commission].
    Gleiter CH; Bieck PR
    Fortschr Med; 1991 Apr; 109(12):267-70. PubMed ID: 1855758
    [No Abstract]   [Full Text] [Related]  

  • 12. Legal requirements for drug testing in children in Germany.
    Hasskarl H
    Pediatr Pharmacol (New York); 1983; 3(3-4):361-6. PubMed ID: 6677882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Take-over of the risk-benefit by the clinical study subject and its regulation].
    Antal J
    Orv Hetil; 2005 Jun; 146(26):1399-404. PubMed ID: 16052982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fair benefits in international medical research.
    Arras JD
    Hastings Cent Rep; 2004; 34(3):3. PubMed ID: 15281717
    [No Abstract]   [Full Text] [Related]  

  • 15. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role].
    Ainsworth MA
    Ugeskr Laeger; 2003 Apr; 165(16):1648-9. PubMed ID: 12756819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Code of professional ethics in clinical research].
    Calès P; Barbare JC; Marteau P; Nouel O; Sautereau D; Valla D
    Gastroenterol Clin Biol; 2001 Nov; 25(11):1016-25. PubMed ID: 11845057
    [No Abstract]   [Full Text] [Related]  

  • 17. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present strategy for new drug development in the USA].
    Shimada Y
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():315-24. PubMed ID: 7986110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.
    Bodick N; Forette F; Hadler D; Harvey RJ; Leber P; McKeith IG; Riekkinen PJ; Rossor MN; Scheltens P; Shimohama S; Spiegel R; Tanaka S; Thal LJ; Urata Y; Whitehouse P; Wilcock G
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():50-3. PubMed ID: 9305517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Medico-legal Commission of Monaco. The statute on the medical profession in times of armed conflict].
    Ann Droit Int Med; 1980-1981; (29):11-37. PubMed ID: 7282023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.